Gitterman Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,407
Closed -$270K 259
2025
Q2
$270K Buy
3,407
+1,068
+46% +$84.9K 0.06% 93
2025
Q1
$210K Buy
2,339
+19
+0.8% +$1.77K 0.06% 114
2024
Q4
$231K Buy
2,320
+313
+16% +$32.3K 0.1% 94
2024
Q3
$228K Sell
2,007
-23
-1% -$2.73K 0.1% 100
2024
Q2
$251K Buy
+2,030
New +$261K 0.1% 76
2022
Q1
Sell
-2,619
Closed -$200K 115
2021
Q4
$200K Buy
+2,619
New +$209K 0.15% 87

Other funds holding MRK

Gitterman Wealth Management's MRK Position: Q3 2025 in Review

Gitterman Wealth Management sold out of Merck (MRK) in Q3 2025, closing a stake of 3,407 shares — an estimated $270K sold.

Gitterman Wealth Management first reported a position in MRK in Q4 2021 and held it in 6 quarters. The position peaked at $270K in Q2 2025. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Gitterman Wealth Management reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • Gitterman Wealth Management sold 3,407 Merck shares in Q3 2025, an estimated $270K.
  • Gitterman Wealth Management first reported a position in Merck in Q4 2021 and held it in 6 quarters.
  • Gitterman Wealth Management's Merck position peaked at $270K in Q2 2025.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Gitterman Wealth Management's 13F filing for Q3 2025, filed 4 Nov 2025.